33 research outputs found
Bioavailability of intravenous versus subcutaneous administration of the dual GC-A and GC-B designer natriuretic peptide cenderitide in healthy canines
Get PDFChronic angiotensin II (AT1) receptor antagonism selectively enhances renal cGMP production with improved renal function in experimental overt congestive heart failure
Get PDFCoadministration of B-type natriuretic peptide and the vasopressin-2 receptor antagonist tolvaptan: a novel physiologic strategy to enhance water and sodium excretion without adversely affecting renal or neurohumoral function in experimental congestive heart failure
Get PDFPharmacokinetic and pharmacodynamic study of a novel chimeric natriuretic peptide, CD-NP, in the normal dog
Get PDFCardiorenal actions of a novel chimeric natriuretic peptide, CD-NP, as compared to C-type natriuretic peptide, in the normal dog
Get PDFChronic angiotensin II (AT1) receptor antagonism selectively enhances renal cGMP production with improved renal function in experimental overt congestive heart failure
No full textCardiorenal actions of a novel chimeric natriuretic peptide, CD-NP, as compared to C-type natriuretic peptide, in the normal dog
No full text
A Novel Chimeric Peptide, ANG1-7/BNP, with Dual In Vitro and In Vivo Actions through the Natriuretic Peptide Receptor and Mas Receptor Systems
No full text
